Navigation Links
MEDRAD Multi Vendor Service Forms Alliance with Wetsco
Date:11/13/2008

Ultrasound repair providers join forces to provide superior customer care

WARRENDALE, Pa., Nov. 13 /PRNewswire/ -- MEDRAD, Inc., Multi Vendor Service announced today that it will form a strategic alliance with Wetsco, one of the most respected leaders in the ultrasound transducer repair industry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO )

This relationship brings together two of the most reputable, high-quality service providers in the ultrasound repair market. By combining Wetsco's unique repair and innovation capabilities with MVS' sales infrastructure, customer care, and world-class repair facility, the two companies will offer a superior customer experience.

Announcing the agreement today is the first of many milestones in this partnership, as subsequent announcements are planned in the next several months.

"This alliance is a great execution of the Multi Vendor Service mission. It will help us to provide the highest quality repair solutions, customer care, and repair innovation in the ultrasound third-party repair market," said Diane Watson, executive director of MEDRAD Multi Vendor Service. "I look forward to sharing additional information about our partnership soon."

"Wetsco will accelerate its ability to deliver innovative repair capabilities as a result of this alliance, while providing the best possible service to its customers," said Dennis Wulf, president of Wetsco.

About Wetsco

Based in Tulsa, Oklahoma, Wetsco is the technology leader in the third-party ultrasound repair market. It is a private company that evaluates and repairs ultrasound probes for OEMs, Independent Service Organizations and other third-party repair providers. Wetsco is a recognized market leader with differentiated repair capabilities, robust quality processes and strong R&D talent. For more information about Wetsco, visit http://www.wetsco.com .

About MEDRAD Multi Vendor Service

MEDRAD's Multi Vendor Service team provides OEM-quality repairs for all brands of MRI coils, ultrasound transducers and ultrasound parts in locations around the world. The MVS team leverage's MEDRAD's 200-plus, field-based representatives to deliver world-class customer service. MVS is recognized in the third-party repair industry for its quality, exceptional customer care, field support, and international presence. For more information about MEDRAD MVS, visit http://www.medrad.com/mvs.

About MEDRAD

MEDRAD, Inc., is a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, MEDRAD's product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment services. Total 2007 revenues were $525 million. MEDRAD is a 2003 recipient of the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is an affiliate of Bayer AG. More company information is available at http://www.medrad.com.

The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at http://www.bayerhealthcare.com.

Cautionary statement regarding forward-looking statements.

Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and MEDRAD's plans and objectives to differ materially from those expressed or implied in the forward-looking statements. MEDRAD, INC. undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise.


'/>"/>
SOURCE MEDRAD, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System
2. MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery
3. MEDRAD(R) Revenues Grow 10 Percent in 2007
4. MEDRAD Mobile MR Injector Meets Challenges of MR Trailers
5. MEDRAD Plant Named IndustryWeek Magazine Award Finalist
6. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
7. GEMS Introduces Ultrasonic Continuous Liquid Level Sensor with Multipoint Switch Capability
8. Polar Introduces the RS800CX Training Management System for Multisport Endurance Athletes
9. WVU Announces Creation of Multimillion Dollar Pediatric Research Institute
10. National Multiple Sclerosis Society New Jersey Metro Chapter Looking for People to Join the Movement
11. Multiple sclerosis progression can be predicted with MRI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... , ... Curemark, LLC announced today that the Blüm Study, a Phase 3 ... with Autism, is now enrolling at three new sites. These new sites are in ... , “There are currently no approved drugs that address the core symptoms of autism,” ...
(Date:2/22/2017)... Setauket, New York (PRWEB) , ... February 22, ... ... main floor entrance and lobby of a new healthcare contact center in Georgia, ... results. , One of the nation’s largest healthcare systems recently invested $51 million ...
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... treatment to the thousands of individuals who have recently fallen victim to America’s opioid ... in Orange County, California, where they are free from the shame, stigma, and ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes ... emergency room, fewer hospital admissions, and better blood pressure and glycemic control, a ... The study can be found here . , The study comes as ...
(Date:2/22/2017)... ... February 22, 2017 , ... Doctors on Liens is continuing its ... Dr. Steven H. Rauchman, practicing at North Valley Eye Medical Group in Mission ... premise liability and other personal injury cases. These injuries have a major impact ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... The U.S. cannabis market is growing ... use in 2016. According to a new report published by ... estimated $7.2 billion in 2016 and is projected to grow ... recreational sales are projected to jump from $2.6 billion in ... The market may grow faster as the estimate was based ...
(Date:2/23/2017)... , Feb. 22, 2017 This report analyzes analyzes the ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. ... Market data and analytics are derived from primary and secondary ...
(Date:2/23/2017)... Ill. , Feb. 23, 2017 Takeda ... subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) and Cognition ... PLC and Ctrl Group Limited, announced a collaboration to ... an Apple Watch wearable to monitor and assess cognitive ... Depression (MDD) is the leading cause of disability ...
Breaking Medicine Technology: